{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T19:57:12Z","timestamp":1790971032321,"version":"4.1.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medicina Cl\u00ednica"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.medcli.2017.04.013","type":"journal-article","created":{"date-parts":[[2017,6,17]],"date-time":"2017-06-17T10:16:33Z","timestamp":1497694593000},"page":"256-260","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Pioderma gangrenoso: terapias cl\u00e1sicas y emergentes"],"prefix":"10.1016","volume":"149","author":[{"given":"Felipe","family":"Soto Vilches","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristi\u00e1n","family":"Vera-Kellet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.medcli.2017.04.013_bib0190","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/S0190-9622(96)90428-4","article-title":"Pyoderma gangrenosum: Classification and management","volume":"34","author":"Powell","year":"1996","journal-title":"J Am Acad Dermatol."},{"key":"10.1016\/j.medcli.2017.04.013_bib0195","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1111\/j.1365-4632.2004.02128.x","article-title":"Pyoderma gangrenosum: Clinicopathologic correlation and proposed diagnostic criteria","volume":"43","author":"Su","year":"2004","journal-title":"Int J Dermatol."},{"key":"10.1016\/j.medcli.2017.04.013_bib0200","doi-asserted-by":"crossref","first-page":"191","DOI":"10.2165\/11595240-000000000-00000","article-title":"Etiology and management of pyoderma gangrenosum: A comprehensive review","volume":"13","author":"Ahronowitz","year":"2012","journal-title":"Am J Clin Dermatol."},{"key":"10.1016\/j.medcli.2017.04.013_bib0205","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1111\/j.1365-2133.2011.10565.x","article-title":"Pyoderma gangrenosum: A retrospective review of patient characteristics, comorbidities and therapy in 103 patients","volume":"165","author":"Binus","year":"2011","journal-title":"Br J Dermatol."},{"key":"10.1016\/j.medcli.2017.04.013_bib0210","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1046\/j.1365-4362.2003.01369.x","article-title":"Case reports and a review of the literature on ulcers mimicking pyoderma gangrenosum","volume":"42","author":"Nguyen","year":"2003","journal-title":"Int J Dermatol."},{"key":"10.1016\/j.medcli.2017.04.013_bib0215","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1038\/jid.2012.130","article-title":"Incidence, mortality, and disease associations of pyoderma gangrenosum in the United Kingdom: A retrospective cohort study","volume":"132","author":"Langan","year":"2012","journal-title":"J Invest Dermatol."},{"key":"10.1016\/j.medcli.2017.04.013_bib0220","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1111\/j.1572-0241.2003.07581.x","article-title":"Infliximab for treatment of pyoderma gangrenosum associated with inflammatory bowel disease","volume":"98","author":"Regueiro","year":"2003","journal-title":"Am J Gastroenterol."},{"key":"10.1016\/j.medcli.2017.04.013_bib0225","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1080\/09546630410031909","article-title":"Review of 26 cases of classical pyoderma gangrenosum: Clinical and therapeutic features","volume":"15","author":"Vidal","year":"2004","journal-title":"J Dermatolog Treat."},{"key":"10.1016\/j.medcli.2017.04.013_bib0230","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00054725-200102000-00001","article-title":"Intravenous cyclosporine in refractory pyoderma gangrenosum complicating inflammatory bowel disease","volume":"7","author":"Friedman","year":"2001","journal-title":"Inflamm Bowel Dis."},{"key":"10.1016\/j.medcli.2017.04.013_bib0235","doi-asserted-by":"crossref","first-page":"h2958","DOI":"10.1136\/bmj.h2958","article-title":"Comparison of the two most commonly used treatments for pyoderma gangrenosum: Results of the STOP GAP randomised controlled trial","volume":"350","author":"Ormerod","year":"2015","journal-title":"BMJ"},{"key":"10.1016\/j.medcli.2017.04.013_bib0240","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1111\/bjd.14619","article-title":"Treatment of pyoderma gangrenosum - Retrospective multicenter analysis of 121 patients","volume":"175","author":"Herberger","year":"2016","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.medcli.2017.04.013_bib0245","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.annder.2015.10.593","article-title":"Caract\u00e9ristiques cliniques et traitement du pyoderma gangrenosum dans la Marne","volume":"143","author":"Anuset","year":"2016","journal-title":"Ann Dermatol Venereol."},{"key":"10.1016\/j.medcli.2017.04.013_bib0250","first-page":"326","article-title":"Treatment of pyoderma gangrenosum with methotrexate","volume":"57","author":"Teitel","year":"1996","journal-title":"Cutis."},{"key":"10.1016\/j.medcli.2017.04.013_bib0255","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.jaad.2004.10.006","article-title":"Treatment recommendations for pyoderma gangrenosum: An evidence-based review of the literature based on more than 350 patients","volume":"53","author":"Reichrath","year":"2005","journal-title":"J Am Acad Dermatol."},{"key":"10.1016\/j.medcli.2017.04.013_bib0260","doi-asserted-by":"crossref","first-page":"277","DOI":"10.4103\/0378-6323.186497","article-title":"Intralesional methotrexate as an adjuvant treatment for pyoderma gangrenosum: A case report","volume":"83","author":"Del Puerto","year":"2017","journal-title":"Indian J Dermatol Venereol Leprol."},{"key":"10.1016\/j.medcli.2017.04.013_bib0265","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1177\/1534734616639172","article-title":"Pyoderma gangrenosum: A report of 27 patients","volume":"15","author":"Ad\u0131\u015fen","year":"2016","journal-title":"Int J Low Extrem Wounds."},{"key":"10.1016\/j.medcli.2017.04.013_bib0270","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.1111\/jdv.13727","article-title":"Systematic review of surgical treatment of pyoderma gangrenosum with negative pressure wound therapy or skin grafting","volume":"31","author":"Pichler","year":"2017","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"10.1016\/j.medcli.2017.04.013_bib0275","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/ddg.12585","article-title":"Therapy of pyoderma gangrenosum in Germany: Results of a survey among wound experts","volume":"13","author":"Al Ghazal","year":"2015","journal-title":"J Dtsch Dermatol Ges."},{"key":"10.1016\/j.medcli.2017.04.013_bib0280","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1097\/SAP.0b013e31829565f3","article-title":"Inpatient management of pyoderma gangrenosum","volume":"74","author":"Cabalag","year":"2015","journal-title":"Ann Plast Surg."},{"key":"10.1016\/j.medcli.2017.04.013_bib0285","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/j.1440-0960.2008.00506.x","article-title":"Treatment of refractory pyoderma gangrenosum with intravenous immunoglobulin","volume":"50","author":"De Zwaan","year":"2009","journal-title":"Australas J Dermatol."},{"key":"10.1016\/j.medcli.2017.04.013_bib0290","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1111\/j.1365-2133.2007.08433.x","article-title":"Intravenous immunoglobulin for pyoderma gangrenosum","volume":"158","author":"Kreuter","year":"2008","journal-title":"Br J Dermatol."},{"key":"10.1016\/j.medcli.2017.04.013_bib0295","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1159\/000368824","article-title":"Intravenous immunoglobulin as salvage therapy in refractory pyoderma gangrenosum: Report of a case and review of the literature","volume":"6","author":"Cafardi","year":"2014","journal-title":"Case Rep Dermatol."},{"key":"10.1016\/j.medcli.2017.04.013_bib0300","doi-asserted-by":"crossref","first-page":"525","DOI":"10.2340\/00015555-2008","article-title":"Effective strategies for the management of pyoderma gangrenosum: A comprehensive review","volume":"95","author":"Patel","year":"2015","journal-title":"Acta Derm Venereol."},{"key":"10.1016\/j.medcli.2017.04.013_bib0305","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1136\/gut.2005.074815","article-title":"Infliximab for the treatment of pyoderma gangrenosum: A randomised, double blind, placebo controlled trial","volume":"55","author":"Brooklyn","year":"2006","journal-title":"Gut."},{"key":"10.1016\/j.medcli.2017.04.013_bib0310","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1111\/j.1365-4632.2007.03286.x","article-title":"Etanercept for the treatment of refractory pyoderma gangrenosum: A brief series","volume":"46","author":"Charles","year":"2007","journal-title":"Int J Dermatol."},{"key":"10.1016\/j.medcli.2017.04.013_bib0315","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1053\/gast.2001.28674","article-title":"Etanercept for active Crohn's disease: A randomized, double-blind, placebo-controlled trial","volume":"121","author":"Sandborn","year":"2001","journal-title":"Gastroenterology."},{"key":"10.1016\/j.medcli.2017.04.013_bib0320","doi-asserted-by":"crossref","first-page":"15","DOI":"10.5070\/D34PH5R1M2","article-title":"Successful treatment of superficial pyoderma gangrenosum associated with hidradenitis suppurativa with adalimumab","volume":"16","author":"Reddick","year":"2010","journal-title":"Dermatol Online J."},{"key":"10.1016\/j.medcli.2017.04.013_bib0325","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s13555-012-0006-6","article-title":"Adalimumab: A treatment option for pyoderma gangrenosum after failure of systemic standard therapies","volume":"2","author":"Hinterberger","year":"2012","journal-title":"Dermatol Ther (Heidelb)"},{"key":"10.1016\/j.medcli.2017.04.013_bib0330","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3109\/09546634.2015.1034075","article-title":"Certolizumab pegol - A new therapeutic option for refractory disseminated pyoderma gangrenosum associated with Crohn's disease","volume":"27","author":"Hurabielle","year":"2016","journal-title":"J Dermatolog Treat."},{"key":"10.1016\/j.medcli.2017.04.013_bib0335","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1001\/archdermatol.2010.393","article-title":"Is topical monotherapy effective for localized pyoderma gangrenosum?","volume":"147","author":"Le Cleach","year":"2011","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.medcli.2017.04.013_bib0340","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1080\/095466301750163518","article-title":"Topical tacrolimus in the management of peristomal pyoderma gangrenosum","volume":"12","author":"Lyon","year":"2001","journal-title":"J Dermatolog Treat."},{"key":"10.1016\/j.medcli.2017.04.013_bib0345","first-page":"51","article-title":"A novel therapy for the treatment of pyoderma gangrenosum","volume":"63","author":"Azizan","year":"2008","journal-title":"Med J Malaysia."},{"key":"10.1016\/j.medcli.2017.04.013_bib0350","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1001\/archsurg.135.5.564","article-title":"Twenty cases of peristomal pyoderma gangrenosum: Diagnostic implications and management","volume":"135","author":"Sheldon","year":"2000","journal-title":"Arch Surg."},{"key":"10.1016\/j.medcli.2017.04.013_bib0355","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1089\/wound.2011.0339","article-title":"Effective strategies for the management of pyoderma gangrenosum","volume":"1","author":"Goodarzi","year":"2012","journal-title":"Adv Wound Care (New Rochelle)."},{"key":"10.1016\/j.medcli.2017.04.013_bib0360","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.jaad.2015.09.009","article-title":"Surgical treatment of pyoderma gangrenosum with negative pressure wound therapy and split thickness skin grafting under adequate immunosuppression is a valuable treatment option: Case series of 15 patients","volume":"74","author":"Pichler","year":"2016","journal-title":"J Am Acad Dermatol."},{"key":"10.1016\/j.medcli.2017.04.013_bib0365","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.jaad.2016.05.044","article-title":"Clinical features, causes, treatments, and outcomes of peristomal pyoderma gangrenosum (PPG) in 44 patients: The Mayo Clinic experience, 1996 through 2013","volume":"75","author":"Barbosa","year":"2016","journal-title":"J Am Acad Dermatol."},{"key":"10.1016\/j.medcli.2017.04.013_bib0370","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1001\/jama.284.12.1546","article-title":"Clinical features and treatment of peristomal pyoderma gangrenosum","volume":"284","author":"Hughes","year":"2000","journal-title":"JAMA"}],"container-title":["Medicina Cl\u00ednica"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775317303433?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775317303433?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T02:15:31Z","timestamp":1692843331000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025775317303433"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":37,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["S0025775317303433"],"URL":"https:\/\/doi.org\/10.1016\/j.medcli.2017.04.013","relation":{},"ISSN":["0025-7753"],"issn-type":[{"value":"0025-7753","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pioderma gangrenoso: terapias cl\u00e1sicas y emergentes","name":"articletitle","label":"Article Title"},{"value":"Medicina Cl\u00ednica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.medcli.2017.04.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}